Overcoming RNA Delivery Challenges: Insights from South American Research
One of the biggest hurdles in RNA-based therapeutics is delivering RNA molecules safely and effectively into the body. Researchers across South America are contributing valuable insights into improving delivery mechanisms suited to regional needs.
RNA molecules are delicate and easily degraded. Effective delivery systems must protect them, guide them to target tissues, and release them at the right time. South American scientists are exploring lipid nanoparticles (LNPs), polymer-based carriers, and peptide systems to solve these challenges.
Different diseases require different delivery strategies. For cancer, targeting RNA molecules to tumor cells without affecting healthy tissues is essential. For genetic disorders, delivery must sometimes reach specific organs such as the liver or nervous system.
Environmental factors in South America, such as varied climate zones, also influence storage and transport stability. Researchers are investigating more durable formulations that can withstand temperature fluctuations—a key requirement for broader access.
Academic collaborations between nanotechnology labs and biomedical institutes are strengthening this research field. These partnerships support the design of new materials, computational modeling, and safety testing.
As delivery methods improve, the practical use of RNA therapeutics in South America becomes increasingly feasible.